{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:51:35Z","timestamp":1791726695105,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T00:00:00Z","timestamp":1502928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T00:00:00Z","timestamp":1502928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21NS087328"],"award-info":[{"award-number":["R21NS087328"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"William and Judith Davis Fund in Neurovascular Surgery Research"},{"name":"Safadi Translational Fellowship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s12975-017-0561-3","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T13:39:43Z","timestamp":1502977183000},"page":"34-43","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations"],"prefix":"10.1007","volume":"9","author":[{"given":"Romuald","family":"Girard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein A.","family":"Zeineddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maged D.","family":"Fam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Mayampurath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changbin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Shenkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Polster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jesselson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Duggan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul-Ghani","family":"Mikati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Christoforidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean Y.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issam A.","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,17]]},"reference":[{"issue":"3","key":"561_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S1474-4422(12)70004-2","volume":"11","author":"R Al-Shahi Salman","year":"2012","unstructured":"Al-Shahi Salman R, Hall JM, Horne MA, Moultrie F, Josephson CB, Bhattacharya JJ, et al. Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study. Lancet Neurol. 2012;11(3):217\u201324. doi:\n                    10.1016\/S1474-4422(12)70004-2\n                    \n                  .","journal-title":"Lancet Neurol"},{"issue":"16","key":"561_CR2","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1093\/hmg\/ddu153","volume":"23","author":"DA McDonald","year":"2014","unstructured":"McDonald DA, Shi C, Shenkar R, Gallione CJ, Akers AL, Li S, et al. Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis. Hum Mol Genet. 2014;23(16):4357\u201370. doi:\n                    10.1093\/hmg\/ddu153\n                    \n                  .","journal-title":"Hum Mol Genet"},{"issue":"2","key":"561_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nm.1911","volume":"15","author":"KJ Whitehead","year":"2009","unstructured":"Whitehead KJ, Chan AC, Navankasattusas S, Koh W, London NR, Ling J, et al. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med. 2009;15(2):177\u201384. doi:\n                    10.1038\/nm.1911\n                    \n                  .","journal-title":"Nat Med"},{"issue":"10","key":"561_CR4","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/jcbfm.2015.98","volume":"35","author":"AG Mikati","year":"2015","unstructured":"Mikati AG, Khanna O, Zhang L, Girard R, Shenkar R, Guo X, et al. Vascular permeability in cerebral cavernous malformations. J Cereb Blood Flow Metab. 2015;35(10):1632\u20139. doi:\n                    10.1038\/jcbfm.2015.98\n                    \n                  .","journal-title":"J Cereb Blood Flow Metab"},{"issue":"7","key":"561_CR5","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3174\/ajnr.A4724","volume":"37","author":"H Tan","year":"2016","unstructured":"Tan H, Zhang L, Mikati AG, Girard R, Khanna O, Fam MD, et al. Quantitative susceptibility mapping in cerebral cavernous malformations: clinical correlations. AJNR Am J Neuroradiol. 2016;37(7):1209\u201315. doi:\n                    10.3174\/ajnr.A4724\n                    \n                  .","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"561_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3171\/2016.5.JNS16687","volume":"127","author":"R Girard","year":"2017","unstructured":"Girard R, Fam MD, Zeineddine HA, Tan H, Mikati AG, Shi C, et al. Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations. J Neurosurg. 2017;127(1):102\u201310. doi:\n                    10.3171\/2016.5.JNS16687\n                    \n                  .","journal-title":"J Neurosurg"},{"issue":"2","key":"561_CR7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11481-016-9670-0","volume":"11","author":"C Shi","year":"2016","unstructured":"Shi C, Shenkar R, Zeineddine HA, Girard R, Fam MD, Austin C, et al. B-cell depletion reduces the maturation of cerebral cavernous malformations in murine models. J NeuroImmune Pharmacol. 2016;11(2):369\u201377. doi:\n                    10.1007\/s11481-016-9670-0\n                    \n                  .","journal-title":"J NeuroImmune Pharmacol"},{"issue":"1\u20132","key":"561_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jneuroim.2014.04.016","volume":"272","author":"C Shi","year":"2014","unstructured":"Shi C, Shenkar R, Kinloch A, Henderson SG, Shaaya M, Chong AS, et al. Immune complex formation and in situ B-cell clonal expansion in human cerebral cavernous malformations. J Neuroimmunol. 2014;272(1\u20132):67\u201375. doi:\n                    10.1016\/j.jneuroim.2014.04.016\n                    \n                  .","journal-title":"J Neuroimmunol"},{"issue":"28","key":"561_CR9","doi-asserted-by":"publisher","first-page":"12640","DOI":"10.1073\/pnas.1000132107","volume":"107","author":"J Wustehube","year":"2010","unstructured":"Wustehube J, Bartol A, Liebler SS, Brutsch R, Zhu Y, Felbor U, et al. Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling. Proc Natl Acad Sci U S A. 2010;107(28):12640\u20135. doi:\n                    10.1073\/pnas.1000132107\n                    \n                  .","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"561_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.devcel.2014.12.016","volume":"32","author":"M Renz","year":"2015","unstructured":"Renz M, Otten C, Faurobert E, Rudolph F, Zhu Y, Boulday G, et al. Regulation of beta1 integrin-Klf2-mediated angiogenesis by CCM proteins. Dev Cell. 2015;32(2):181\u201390. doi:\n                    10.1016\/j.devcel.2014.12.016\n                    \n                  .","journal-title":"Dev Cell"},{"key":"561_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jocn.2016.12.023","volume":"37","author":"S Noshiro","year":"2017","unstructured":"Noshiro S, Mikami T, Kataoka-Sasaki Y, Sasaki M, Ohnishi H, Ohtaki S, et al. Co-expression of tissue factor and IL-6 in immature endothelial cells of cerebral cavernous malformations. J Clin Neurosci. 2017;37:83\u201390. doi:\n                    10.1016\/j.jocn.2016.12.023\n                    \n                  .","journal-title":"J Clin Neurosci"},{"issue":"6","key":"561_CR12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1159\/000369200","volume":"38","author":"H Choquet","year":"2014","unstructured":"Choquet H, Pawlikowska L, Nelson J, McCulloch CE, Akers A, Baca B, et al. Polymorphisms in inflammatory and immune response genes associated with cerebral cavernous malformation type 1 severity. Cerebrovasc Dis. 2014;38(6):433\u201340. doi:\n                    10.1159\/000369200\n                    \n                  .","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"561_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrneurol.2014.232","volume":"11","author":"A Lleo","year":"2015","unstructured":"Lleo A, Cavedo E, Parnetti L, Vanderstichele H, Herukka SK, Andreasen N, et al. Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases. Nat Rev Neurol. 2015;11(1):41\u201355. doi:\n                    10.1038\/nrneurol.2014.232\n                    \n                  .","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"561_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/cpt.136","volume":"98","author":"S Amur","year":"2015","unstructured":"Amur S, LaVange L, Zineh I, Buckman-Garner S, Woodcock J. Biomarker qualification: toward a multiple stakeholder framework for biomarker development, regulatory acceptance, and utilization. Clin Pharmacol Ther. 2015;98(1):34\u201346. doi:\n                    10.1002\/cpt.136\n                    \n                  .","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"561_CR15","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.2217\/bmm.15.90","volume":"9","author":"SG Amur","year":"2015","unstructured":"Amur SG, Sanyal S, Chakravarty AG, Noone MH, Kaiser J, McCune S, et al. Building a roadmap to biomarker qualification: challenges and opportunities. Biomark Med. 2015;9(11):1095\u2013105. doi:\n                    10.2217\/bmm.15.90\n                    \n                  .","journal-title":"Biomark Med"},{"issue":"3","key":"561_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2217\/bmm.15.118","volume":"10","author":"R Girard","year":"2016","unstructured":"Girard R, Khanna O, Shenkar R, Zhang L, Wu M, Jesselson M, et al. Peripheral plasma vitamin D and non-HDL cholesterol reflect the severity of cerebral cavernous malformation disease. Biomark Med. 2016;10(3):255\u201364. doi:\n                    10.2217\/bmm.15.118\n                    \n                  .","journal-title":"Biomark Med"},{"issue":"1","key":"561_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000356839","volume":"37","author":"H Choquet","year":"2014","unstructured":"Choquet H, Nelson J, Pawlikowska L, McCulloch CE, Akers A, Baca B, et al. Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation. Cerebrovasc Dis. 2014;37(1):57\u201363. doi:\n                    10.1159\/000356839\n                    \n                  .","journal-title":"Cerebrovasc Dis"},{"issue":"12","key":"561_CR18","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1161\/STROKEAHA.108.515544","volume":"39","author":"R Al-Shahi Salman","year":"2008","unstructured":"Al-Shahi Salman R, Berg MJ, Morrison L, Awad IA, Angioma Alliance Scientific Advisory B. Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Angioma Alliance Scientific Advisory Board. Stroke. 2008;39(12):3222\u201330. doi:\n                    10.1161\/STROKEAHA.108.515544\n                    \n                  .","journal-title":"Stroke"},{"issue":"5","key":"561_CR19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/MCO.0b013e32833cf3bc","volume":"13","author":"X Zhou","year":"2010","unstructured":"Zhou X, Fragala MS, McElhaney JE, Kuchel GA. Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research. Curr Opin Clin Nutr Metab Care. 2010;13(5):541\u20137. doi:\n                    10.1097\/MCO.0b013e32833cf3bc\n                    \n                  .","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"20","key":"561_CR20","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.108.804146","volume":"118","author":"A Langsted","year":"2008","unstructured":"Langsted A, Freiberg JJ, Nordestgaard BG. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation. 2008;118(20):2047\u201356. doi:\n                    10.1161\/CIRCULATIONAHA.108.804146\n                    \n                  .","journal-title":"Circulation"},{"issue":"12","key":"561_CR21","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/nm.1878","volume":"14","author":"PF Fabene","year":"2008","unstructured":"Fabene PF, Navarro Mora G, Martinello M, Rossi B, Merigo F, Ottoboni L, et al. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med. 2008;14(12):1377\u201383. doi:\n                    10.1038\/nm.1878\n                    \n                  .","journal-title":"Nat Med"},{"issue":"4","key":"561_CR22","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1189\/jlb.0710432","volume":"89","author":"B Rossi","year":"2011","unstructured":"Rossi B, Angiari S, Zenaro E, Budui SL, Constantin G. Vascular inflammation in central nervous system diseases: adhesion receptors controlling leukocyte-endothelial interactions. J Leukoc Biol. 2011;89(4):539\u201356. doi:\n                    10.1189\/jlb.0710432\n                    \n                  .","journal-title":"J Leukoc Biol"},{"issue":"2","key":"561_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S1474-4422(09)70016-X","volume":"8","author":"GA Rosenberg","year":"2009","unstructured":"Rosenberg GA. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol. 2009;8(2):205\u201316. doi:\n                    10.1016\/S1474-4422(09)70016-X\n                    \n                  .","journal-title":"Lancet Neurol"},{"issue":"2","key":"561_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.9758\/cpn.2013.11.2.45","volume":"11","author":"H Mizoguchi","year":"2013","unstructured":"Mizoguchi H, Yamada K. Roles of matrix metalloproteinases and their targets in epileptogenesis and seizures. Clin Psychopharmacol Neurosci. 2013;11(2):45\u201352. doi:\n                    10.9758\/cpn.2013.11.2.45\n                    \n                  .","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"1","key":"561_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40348-014-0006-y","volume":"1","author":"C Ikonomidou","year":"2014","unstructured":"Ikonomidou C. Matrix metalloproteinases and epileptogenesis. Mol Cell Pediatr. 2014;1(1):6. doi:\n                    10.1186\/s40348-014-0006-y\n                    \n                  .","journal-title":"Mol Cell Pediatr"},{"issue":"4","key":"561_CR26","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/jcbfm.2009.248","volume":"30","author":"AT Bauer","year":"2010","unstructured":"Bauer AT, Burgers HF, Rabie T, Marti HH. Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab. 2010;30(4):837\u201348. doi:\n                    10.1038\/jcbfm.2009.248\n                    \n                  .","journal-title":"J Cereb Blood Flow Metab"},{"issue":"8","key":"561_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020599","volume":"6","author":"S Feng","year":"2011","unstructured":"Feng S, Cen J, Huang Y, Shen H, Yao L, Wang Y, et al. Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins. PLoS One. 2011;6(8):e20599. doi:\n                    10.1371\/journal.pone.0020599\n                    \n                  .","journal-title":"PLoS One"},{"issue":"2","key":"561_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00701-006-0929-8","volume":"149","author":"M Fujimura","year":"2007","unstructured":"Fujimura M, Watanabe M, Shimizu H, Tominaga T. Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMP) in cerebral cavernous malformations: immunohistochemical analysis of MMP-2, -9 and TIMP-2. Acta Neurochir. 2007;149(2):179\u2013183; discussion 83. doi:\n                    10.1007\/s00701-006-0929-8\n                    \n                  .","journal-title":"Acta Neurochir"},{"issue":"4","key":"561_CR29","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/sj.jcbfm.9600375","volume":"27","author":"Y Yang","year":"2007","unstructured":"Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab. 2007;27(4):697\u2013709. doi:\n                    10.1038\/sj.jcbfm.9600375\n                    \n                  .","journal-title":"J Cereb Blood Flow Metab"},{"key":"561_CR30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1742-2094-10-80","volume":"10","author":"YJ Li","year":"2013","unstructured":"Li YJ, Wang ZH, Zhang B, Zhe X, Wang MJ, Shi ST, et al. Disruption of the blood-brain barrier after generalized tonic-clonic seizures correlates with cerebrospinal fluid MMP-9 levels. J Neuroinflammation. 2013;10:80. doi:\n                    10.1186\/1742-2094-10-80\n                    \n                  .","journal-title":"J Neuroinflammation"},{"key":"561_CR31","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.eplepsyres.2016.02.009","volume":"122","author":"R Wang","year":"2016","unstructured":"Wang R, Zeng GQ, Tong RZ, Zhou D, Hong Z. Serum matrix metalloproteinase-2: a potential biomarker for diagnosis of epilepsy. Epilepsy Res. 2016;122:114\u20139. doi:\n                    10.1016\/j.eplepsyres.2016.02.009\n                    \n                  .","journal-title":"Epilepsy Res"},{"issue":"5","key":"561_CR32","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/ana.410410519","volume":"41","author":"MJ Alberts","year":"1997","unstructured":"Alberts MJ, Davis JP, Graffagnino C, McClenny C, Delong D, Granger C, et al. Endoglin gene polymorphism as a risk factor for sporadic intracerebral hemorrhage. Ann Neurol. 1997;41(5):683\u20136. doi:\n                    10.1002\/ana.410410519\n                    \n                  .","journal-title":"Ann Neurol"},{"issue":"4","key":"561_CR33","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/(SICI)1098-1004(1998)11:4<286::AID-HUMU6>3.0.CO;2-B","volume":"11","author":"CJ Gallione","year":"1998","unstructured":"Gallione CJ, Klaus DJ, Yeh EY, Stenzel TT, Xue Y, Anthony KB, et al. Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles. Hum Mutat. 1998;11(4):286\u201394. doi:\n                    10.1002\/(SICI)1098-1004(1998)11:4<286::AID-HUMU6>3.0.CO;2-B\n                    \n                  .","journal-title":"Hum Mutat"},{"issue":"1","key":"561_CR34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00439-010-0825-4","volume":"128","author":"J Richards-Yutz","year":"2010","unstructured":"Richards-Yutz J, Grant K, Chao EC, Walther SE, Ganguly A. Update on molecular diagnosis of hereditary hemorrhagic telangiectasia. Hum Genet. 2010;128(1):61\u201377. doi:\n                    10.1007\/s00439-010-0825-4\n                    \n                  .","journal-title":"Hum Genet"},{"issue":"3","key":"561_CR35","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1227\/NEU.0b013e318219569f","volume":"69","author":"Y Zhu","year":"2011","unstructured":"Zhu Y, Wu Q, Fass M, Xu JF, You C, Muller O, et al. In vitro characterization of the angiogenic phenotype and genotype of the endothelia derived from sporadic cerebral cavernous malformations. Neurosurgery. 2011;69(3):722\u2013731; discussion 31-2. doi:\n                    10.1227\/NEU.0b013e318219569f\n                    \n                  .","journal-title":"Neurosurgery"},{"key":"561_CR36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1471-2377-13-32","volume":"13","author":"R Matsuo","year":"2013","unstructured":"Matsuo R, Ago T, Kamouchi M, Kuroda J, Kuwashiro T, Hata J, et al. Clinical significance of plasma VEGF value in ischemic stroke\u2014research for biomarkers in ischemic stroke (REBIOS) study. BMC Neurol. 2013;13:32. doi:\n                    10.1186\/1471-2377-13-32\n                    \n                  .","journal-title":"BMC Neurol"},{"issue":"8","key":"561_CR37","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1161\/01.STR.31.8.1863","volume":"31","author":"M Slevin","year":"2000","unstructured":"Slevin M, Krupinski J, Slowik A, Kumar P, Szczudlik A, Gaffney J. Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke. Stroke. 2000;31(8):1863\u201370.","journal-title":"Stroke"},{"issue":"11","key":"561_CR38","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1001\/archneur.60.11.1613","volume":"60","author":"KH Jung","year":"2003","unstructured":"Jung KH, Chu K, Jeong SW, Park HK, Bae HJ, Yoon BW. Cerebral cavernous malformations with dynamic and progressive course: correlation study with vascular endothelial growth factor. Arch Neurol. 2003;60(11):1613\u20138. doi:\n                    10.1001\/archneur.60.11.1613\n                    \n                  .","journal-title":"Arch Neurol"},{"issue":"1","key":"561_CR39","doi-asserted-by":"publisher","DOI":"10.3171\/foc.2006.21.1.4","volume":"21","author":"F Maiuri","year":"2006","unstructured":"Maiuri F, Cappabianca P, Gangemi M, De Caro MB, Esposito F, Pettinato G, et al. Clinical progression and familial occurrence of cerebral cavernous angiomas: the role of angiogenic and growth factors. Neurosurg Focus. 2006;21(1):e3.","journal-title":"Neurosurg Focus"},{"issue":"24","key":"561_CR40","doi-asserted-by":"publisher","first-page":"8686","DOI":"10.1073\/pnas.0500419102","volume":"102","author":"PJ Murray","year":"2005","unstructured":"Murray PJ. The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. Proc Natl Acad Sci U S A. 2005;102(24):8686\u201391. doi:\n                    10.1073\/pnas.0500419102\n                    \n                  .","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"561_CR41","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cytogfr.2010.09.002","volume":"21","author":"R Sabat","year":"2010","unstructured":"Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, Wolk K, et al. Biology of interleukin-10. Cytokine Growth Factor Rev. 2010;21(5):331\u201344. doi:\n                    10.1016\/j.cytogfr.2010.09.002\n                    \n                  .","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"561_CR42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.immuni.2014.06.013","volume":"41","author":"S Epelman","year":"2014","unstructured":"Epelman S, Lavine KJ, Randolph GJ. Origin and functions of tissue macrophages. Immunity. 2014;41(1):21\u201335. doi:\n                    10.1016\/j.immuni.2014.06.013\n                    \n                  .","journal-title":"Immunity"},{"issue":"3\u20134","key":"561_CR43","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00424-017-1944-8","volume":"469","author":"M Nairz","year":"2017","unstructured":"Nairz M, Theurl I, Swirski FK, Weiss G. \u201cPumping iron\u201d\u2014how macrophages handle iron at the systemic, microenvironmental, and cellular levels. Pflugers Arch. 2017;469(3\u20134):397\u2013418. doi:\n                    10.1007\/s00424-017-1944-8\n                    \n                  .","journal-title":"Pflugers Arch"},{"issue":"3","key":"561_CR44","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/MOH.0b013e328345a4b9","volume":"18","author":"NR London","year":"2011","unstructured":"London NR, Li DY. Robo4-dependent slit signaling stabilizes the vasculature during pathologic angiogenesis and cytokine storm. Curr Opin Hematol. 2011;18(3):186\u201390. doi:\n                    10.1097\/MOH.0b013e328345a4b9\n                    \n                  .","journal-title":"Curr Opin Hematol"},{"key":"561_CR45","doi-asserted-by":"publisher","first-page":"683025","DOI":"10.1155\/2014\/683025","volume":"2014","author":"SS Yadav","year":"2014","unstructured":"Yadav SS, Narayan G. Role of ROBO4 signalling in developmental and pathological angiogenesis. Biomed Res Int. 2014;2014:683025. doi:\n                    10.1155\/2014\/683025\n                    \n                  .","journal-title":"Biomed Res Int"},{"issue":"7597","key":"561_CR46","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nature17178","volume":"532","author":"Z Zhou","year":"2016","unstructured":"Zhou Z, Tang AT, Wong WY, Bamezai S, Goddard LM, Shenkar R, et al. Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2\/4 signalling. Nature. 2016;532(7597):122\u20136. doi:\n                    10.1038\/nature17178\n                    \n                  .","journal-title":"Nature"},{"issue":"6301","key":"561_CR47","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.aag2590","volume":"353","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM. How neuroinflammation contributes to neurodegeneration. Science. 2016;353(6301):777\u201383. doi:\n                    10.1126\/science.aag2590\n                    \n                  .","journal-title":"Science"},{"key":"561_CR48","doi-asserted-by":"crossref","unstructured":"Di Bari M, Di Pinto G, Reale M, Mengod G, Tata AM. Cholinergic system and neuroinflammation: implication in multiple sclerosis. Cent Nerv Syst Agents Med Chem. 2016;","DOI":"10.2174\/1871524916666160822115133"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12975-017-0561-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-017-0561-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-017-0561-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T17:47:26Z","timestamp":1589737646000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12975-017-0561-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,17]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["561"],"URL":"https:\/\/doi.org\/10.1007\/s12975-017-0561-3","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,17]]},"assertion":[{"value":"9 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in this study involving human participants were in accordance to the Declaration of Helsinki and approved by The University of Chicago Institutional Review Board (IRB). The ethical principles guiding the IRB are consistent with The Belmont Report and comply with the rules and regulations of The Federal Policy for the Protection of Human Subjects (56 FR 28003).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}